Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
The findings from our real-world cohort study revealed the (1) promising value of ctDNA as a prognostic biomarker for relapse in curatively resected BTC and (2) potential early detectability of recurrence by ctDNA compared with standard surveillance.
Authors
- Adham Jurdi (ORCID: https://orcid.org/0000-0002-2985-3053)
- Shruti Sharma
- Vasily N. Aushev (ORCID: https://orcid.org/0000-0001-8003-358X)
- Minetta C. Liu (ORCID: https://orcid.org/0000-0002-8206-5232)
- Rutika Mehta (ORCID: https://orcid.org/0000-0002-1454-053X)
- Aiwu Ruth He (ORCID: https://orcid.org/0000-0002-2104-0816)
- Richard D. Kim (ORCID: https://orcid.org/0000-0002-8448-844X)
- Jason W. Denbo (ORCID: https://orcid.org/0000-0002-3973-1738)
- Charuta C. Palsuledesai (ORCID: https://orcid.org/0000-0002-3850-260X)
- James Yu (ORCID: https://orcid.org/0000-0001-6793-0008)
- Catherine Bridges (ORCID: https://orcid.org/0000-0003-1101-0848)
- Mahmoud Ouf (ORCID: https://orcid.org/0009-0004-9799-3498)
- Daniel A. Anaya (ORCID: https://orcid.org/0000-0002-6569-3931)
- Antony Tin (ORCID: https://orcid.org/0009-0007-1602-2123)
Institutions
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
- Moffitt Cancer Center (US)
- Natera (United States) (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1200/po-24-00443
- Citations
- 9
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 18.06